IT1153182B - PHARMACEUTICAL FORMULATIONS INCLUDING HUMAN INSULIN AND HUMAN C-PEPTIDE - Google Patents

PHARMACEUTICAL FORMULATIONS INCLUDING HUMAN INSULIN AND HUMAN C-PEPTIDE

Info

Publication number
IT1153182B
IT1153182B IT8223017A IT2301782A IT1153182B IT 1153182 B IT1153182 B IT 1153182B IT 8223017 A IT8223017 A IT 8223017A IT 2301782 A IT2301782 A IT 2301782A IT 1153182 B IT1153182 B IT 1153182B
Authority
IT
Italy
Prior art keywords
human
peptide
pharmaceutical formulations
formulations including
human insulin
Prior art date
Application number
IT8223017A
Other languages
Italian (it)
Other versions
IT8223017A0 (en
Inventor
Ronald Eugene Chance
Bruce Hill Frank
John Allison Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IT8223017A0 publication Critical patent/IT8223017A0/en
Application granted granted Critical
Publication of IT1153182B publication Critical patent/IT1153182B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IT8223017A 1981-08-27 1982-08-27 PHARMACEUTICAL FORMULATIONS INCLUDING HUMAN INSULIN AND HUMAN C-PEPTIDE IT1153182B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (2)

Publication Number Publication Date
IT8223017A0 IT8223017A0 (en) 1982-08-27
IT1153182B true IT1153182B (en) 1987-01-14

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8223017A IT1153182B (en) 1981-08-27 1982-08-27 PHARMACEUTICAL FORMULATIONS INCLUDING HUMAN INSULIN AND HUMAN C-PEPTIDE

Country Status (20)

Country Link
JP (1) JPS5846024A (en)
AU (1) AU551879B2 (en)
BE (1) BE894185A (en)
CA (1) CA1176158A (en)
CH (1) CH650679A5 (en)
DE (1) DE3232034A1 (en)
DZ (1) DZ452A1 (en)
FR (1) FR2513126B1 (en)
GB (1) GB2104382B (en)
IE (1) IE54119B1 (en)
IL (1) IL66611A0 (en)
IT (1) IT1153182B (en)
LU (1) LU84359A1 (en)
MW (1) MW3882A1 (en)
NL (1) NL192192C (en)
NZ (1) NZ201682A (en)
PH (1) PH19361A (en)
SE (1) SE460334B (en)
ZA (1) ZA826159B (en)
ZW (1) ZW17482A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (en) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt PHARMACEUTICAL AGENT FOR TREATING THE DIABETES MELLITUS
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
AU8175387A (en) * 1986-10-20 1988-05-06 Novo Industri A/S Protamine zinc insulin preparations
IE62879B1 (en) * 1987-02-25 1995-03-08 Novo Nordisk As Novel insulin derivatives
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
EP0303308B1 (en) * 1987-08-14 1991-05-29 Akzo N.V. Preparation for preventing or combating complications in diabetes
SE520392C2 (en) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specific peptides for the treatment of diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
CN101060856B (en) * 2004-11-22 2011-01-19 诺和诺德公司 Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
WO2010033207A1 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of therapeutic peptides
KR20130115086A (en) * 2010-05-17 2013-10-21 세빅스 인코포레이티드 Pegylated c-peptide
CN104220086A (en) 2011-11-17 2014-12-17 塞比克斯股份公司 PEGylated C-peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (en) * 1953-09-08 1958-05-31 British Drug Houses Ltd Process for the production of an insulin preparation with an extended duration of action

Also Published As

Publication number Publication date
NL192192C (en) 1997-03-04
GB2104382B (en) 1984-12-19
ZA826159B (en) 1984-04-25
NL192192B (en) 1996-11-01
AU551879B2 (en) 1986-05-15
DE3232034C2 (en) 1991-04-11
IL66611A0 (en) 1982-12-31
AU8759482A (en) 1983-03-03
NZ201682A (en) 1985-08-16
SE460334B (en) 1989-10-02
SE8204873D0 (en) 1982-08-25
JPS5846024A (en) 1983-03-17
DZ452A1 (en) 2004-09-13
MW3882A1 (en) 1984-07-11
FR2513126B1 (en) 1986-04-18
GB2104382A (en) 1983-03-09
IE822064L (en) 1983-02-27
IE54119B1 (en) 1989-06-21
IT8223017A0 (en) 1982-08-27
DE3232034A1 (en) 1983-03-10
CH650679A5 (en) 1985-08-15
NL8203315A (en) 1983-03-16
PH19361A (en) 1986-04-02
BE894185A (en) 1983-02-24
FR2513126A1 (en) 1983-03-25
ZW17482A1 (en) 1982-11-17
CA1176158A (en) 1984-10-16
LU84359A1 (en) 1983-02-28
SE8204873L (en) 1983-02-28

Similar Documents

Publication Publication Date Title
IT1218469B (en) PHYSIOLOGICALLY ETTIVE HUMAN POLYPEPTIDE
IT1153182B (en) PHARMACEUTICAL FORMULATIONS INCLUDING HUMAN INSULIN AND HUMAN C-PEPTIDE
IT1153181B (en) PHARMACEUTICAL FORMULATIONS INCLUDING HUMAN INSULIN AND HUMAN PROINSULIN
DK13990A (en) SUPERACTIVE HUMAN INSULIN ANALOGUE
ZW17382A1 (en) Human proinsulin pharmaceutical formulations
ZW17682A1 (en) Pharmaceutical formulations comprising human insulin human c-peptide and human proinsulin
JO1236B1 (en) pharmaceutical formulations comprising human insulin and human c-peptide
JO1238B1 (en) pharmaceutical formulations comprising human insulin ,human c-peptide ,and human proinsuline
JO1209B1 (en) Pharmaceutical formulations comprising human insulin and human proinsulin.
BE885510A (en) OMNI-POTENT MEDICINE FOR MULTIPLE SCLEROSIS AND ARTERIO-SCLEROSIS THERAPEUTICS
IE812104L (en) Novel insulin formulations based on human insulin
RO88841A2 (en) DERMATOLOGICAL MEDICINE

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970717